Skip to Content

Bayer AG ADR BAYRY

Morningstar Rating
$7.04 −0.02 (0.21%)
View Full Chart
Unlock our analysis with Morningstar Investor

Company Report

Price vs Fair Value

BAYRY is trading at a 62% discount.
Price
$7.05
Fair Value
$65.40
Uncertainty
High
1-Star Price
$38.57
5-Star Price
$95.20
Economic Moat
Lcpnhf
Capital Allocation
Jlrb

Bulls Say, Bears Say

Bulls

Several drugs, including recently launched cancer drugs, hold potential for further gains and have relatively steady pricing power partly based on excellent clinical data.

Bears

Biosimilar pressures to long-acting Eylea could emerge more quickly than expected if patents on the new version of the drug lack differentiation versus the short-acting version.

Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BAYRY is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$7.06
Day Range
$6.987.10
52-Week Range
$6.9616.84
Bid/Ask
$6.98 / $7.12
Market Cap
$27.67 Bil
Volume/Avg
4.4 Mil / 2.0 Mil

Key Statistics

Price/Earnings (Normalized)
4.09
Price/Sales
0.54
Dividend Yield (Trailing)
9.36%
Dividend Yield (Forward)
0.42%
Total Yield
9.38%

Company Profile

Bayer is a German healthcare and agriculture conglomerate. Healthcare provides close to half of the company's sales and includes pharmaceutical drugs as well as vitamins and other consumer healthcare products. The firm also has a crop science business that includes seeds, pesticides, herbicides, and fungicides, which was expanded through the acquisition of Monsanto.
Sector
Healthcare
Industry
Drug Manufacturers - General
Stock Style Box
Large Value
Total Number of Employees
99,723

Competitors

Valuation

Metric
BAYRY
BASFY
PFE
Price/Earnings (Normalized)
4.0920.4713.96
Price/Book Value
0.761.241.63
Price/Sales
0.540.652.48
Price/Cash Flow
3.347.9713.33
Price/Earnings
BAYRY
BASFY
PFE

Financial Strength

Metric
BAYRY
BASFY
PFE
Quick Ratio
0.791.060.58
Current Ratio
1.271.980.91
Interest Coverage
−0.031.970.74
Quick Ratio
BAYRY
BASFY
PFE

Profitability

Metric
BAYRY
BASFY
PFE
Return on Assets (Normalized)
5.19%3.00%4.98%
Return on Equity (Normalized)
17.17%6.46%10.90%
Return on Invested Capital (Normalized)
9.39%4.68%7.28%
Return on Assets
BAYRY
BASFY
PFE
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - General Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
LLY
Eli Lilly and CoJnndrqsrnpWdtw$709.2 Bil
JNJ
Johnson & JohnsonCvhkchcXjcg$351.2 Bil
MRK
Merck & Co IncKdclymfvwBcfw$317.6 Bil
ABBV
AbbVie IncScqlqmmvXjwy$291.6 Bil
AZN
AstraZeneca PLC ADRVcschjnbGzb$210.7 Bil
RHHBY
Roche Holding AG ADRCqgrrcjgmHmq$194.6 Bil
NVS
Novartis AG ADRDcfvskrfNvt$190.0 Bil
PFE
Pfizer IncSxgyzrpwsSxrc$143.9 Bil
AMGN
Amgen IncDjjkyycfQwm$141.6 Bil
SNY
Sanofi SA ADRGpxcfnqnfVmzf$113.5 Bil

Sponsor Center